Spain · AEMPS CIMA
BALZAK PLUS 20 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73437
- Form
- COMPRIMIDO RECUBIERTO CON PELÍCULA
- Composition / generic term
- olmesartán + amlodipino + hidroclorotiazida
- Source strength
- 20 mg/5mg/12,5 mg
- Authorisation holder
- Menarini International Operations Luxembourg S.A.
- Marketed in source snapshot
- Yes
Source-listed ingredients
- OLMESARTAN MEDOXOMILO — 20,000 mg
- AMLODIPINO BESILATO — 6,944 mg
- HIDROCLOROTIAZIDA — 12,500 mg
These values do not establish equivalence or a dose recommendation.
Packages
- BALZAK PLUS 20 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos
- BALZAK PLUS 20 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 500 comprimidos
Source and coverage
Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Spain records →